Shorter Fasting After Endoscopic Submucosal Dissection Feasible

This article originally appeared here.
Share this content:
Shorter Fasting After Endoscopic Submucosal Dissection Feasible
Shorter Fasting After Endoscopic Submucosal Dissection Feasible

WEDNESDAY, June 28, 2017 (HealthDay News) -- For patients undergoing endoscopic submucosal dissection (ESD), a short fasting period after the procedure is associated with shorter hospital stay and greater patient satisfaction, with no impact on discomfort or bleeding, according to a study published online June 23 in the Journal of Digestive Diseases.

Kwang Hoon Oh, M.D., from Ulsan University College of Medicine in Gangneung, South Korea, and colleagues enrolled patients into a short and long fasting group. In the short fasting group, patients fasted until the next day after ESD, while patients fasted until two days after ESD in the long fasting group. Immediately prior to restarting diet, a second-look endoscopy was performed. Data were analyzed from 101 patients.

The researchers found that reports of epigastric pain, heartburn, regurgitation, nausea, and vomiting after diet did not differ between the groups. Upon second-look endoscopy, both groups had similar rates of hemostasis (26 versus 31.4 percent; P = 0.551) and bleeding rates (4 versus 0 percent; P = 0.149). The short fasting group had significantly shorter duration of hospital stay than the long fasting group (4.12 versus 5.11 days; P < 0.001), as well as greater patient satisfaction (P = 0.003).

"The short fasting period does not cause discomfort related to ESD nor does it influence post ESD bleeding," the authors write. "Moreover, the short fasting protocol results in shorter hospital stays and greater patient satisfaction."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Treatment for Acute Lymphoblastic Leukemia

FDA Approves New Treatment for Acute Lymphoblastic Leukemia

For patients with relapsed or refractory B-cell ALL who have received one or two prior treatments

Online Nursing Education Can Up Patient Use of VTE Prophylaxis

Online Nursing Education Can Up Patient Use of ...

Online training aims to make sure those hospitalized get treatment to prevent venous thromboembolism

On-Pump CABG Leads to Higher Rates of Five-Year Survival

On-Pump CABG Leads to Higher Rates of Five-Year ...

Study compared coronary-artery bypass grafting surgery, with/without cardiopulmonary bypass

is free, fast, and customized just for you!

Already a member?

Sign In Now »